We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Fully Integrated Solution Introduced for Clinical Chemistry

By LabMedica International staff writers
Posted on 30 Apr 2009
A new clinical chemistry platform optimizes laboratory operations and enables end users to focus on patient outcomes and patient satisfaction.

The new product has been introduced by ELITech Clinical Systems (Puteaux, France). More...
The recent acquisition of Vital Scientific and the established presence of Seppim in the ELITech Group enable the combination of broad manufacturing abilities in clinical chemistry.

ELITech is approaching a system that offers and provides the worldwide clinical chemistry market with a unique platform. The company's new product line connects and reinforces the association between the Group's analyzer family and complete range of ready-to-use reagents.

Supplier and distributor to the in vitro diagnostics (IVD) market, ELITech operates globally, leveraging products from its own biochemistry and microbiology manufacturing facilities as well as third party products. The ELITech Group provides a broad range of products for routine diagnosis use as well as niche products for niche markets. The company's range includes clinical chemistry analyzers and reagents, slide stainers, osmometers, cystic fibrosis sweat test systems, automated electrophoresis equipment, and microbiological products.

Related Links:
ELItech Clinical Systems



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Clinical Informatics Platform
CLARION™
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.